Claude Nicaise, M.D.
Claude Nicaise, M.D. has served as a member of our Board since June 2015. He currently serves as a member and chair of the compensation committee and as a member of the research and development committee of the Board.
Dr. Nicaise is the owner of Clinical Regulatory Services, a company providing advice on clinical and regulatory matters to biotechnology companies.
He has served as an Executive Vice President Regulatory at Ovid Therapeutics Inc., a company that develops medicines for orphan diseases of the brain, from 2015. Prior to that, Dr. Nicaise was a Senior Vice President of Strategic Development and Global Regulatory Affairs at Alexion Pharmaceuticals from 2008 to 2014. From 1983 to 2008, Dr. Nicaise served in various positions of increasing responsibility at Bristol-Myers Squibb, including the following senior management positions: Vice-President of Global Development, Vice-President Worldwide Regulatory Science and Strategy, and leadership positions in Oncology, Infectious Disease and NeuroScience development. Our nominating and corporate governance committee believes that Dr. Nicaise’s significant experience in the pharmaceuticals sector, including in clinical and regulatory affairs, qualifies him for service as a member of the Board.
Dr. Nicaise received his medical degree from the Universite libre de Bruxelles in Belgium.
Sarepta Therapeutics – J.P. Morgan 2020 Presentation
Sarepta Therapeutics 2019 Corporate Presentation
Latest Annual Report( FY 2018 )
R&D Day 2018 Presentation